Low immunization coverage is one of the leading causes for the failure of measles elimination programs4 5. Problems related to the vaccine have also been described33. Krugman12 believes that these problems can be considered insignificant from the epidemiologic point of view and that adequate immunization is sufficient to protect more than 95 % of vaccinated children, for a longer period.
However, an increase in the number of measles cases in previously vaccinated children has been described by different authors5 7 9 15 29 31 33. The reasons for vaccine failure can be related to: improper storage or handling of the vaccine leading to inactivation o f the live virus11 23 24 29 ; neutralization of the vaccine virus by maternal antibodies or those artificially administered (gamma globulin)2 17 28 29 or "primary vaccine failure" , in about 5 % of the vaccinees23. Currier and associates6 consider the age at vaccination as the only factor from the previously related ones capable of causing a significant increase in measles attack rate in vaccinated children.
The objective of the present research was to study measles antibodies, in the years following vaccination, of previously vaccinated children in the Public Health Units of the Municipalities of Niterói and SãoGonçalo, Stateof RiodeJaneiro, correlating the results with the number of doses of vaccine and the child's age at vaccination.
MATERIAL AND METHODS
Study population. The sample chosen at random was 684 children who attended for various reasons some selected primary health units, public orprivate, from March 1985 to February 1986, in the Municipalities of Niterói and São Gonçalo, State of Rio de Janeiro.
Study design. Children were divided into three groups according to their ages at measles vaccination and number of doses received (confirmed by vaccination cards). A group of unvaccinated children with a history of measles in the past based on the criteria established by the Centers for Disease Control, i. e ., fever, cough, typical rash lasting three or more days and catarrhal symptoms served as Controls.
Group A, comprising 341 children who had received a single one dose under one year of age. 26:77-82, abr-jun, 1993. Group B, comprising 101 children who had received a single dose at the age of one.
Group C, comprising 79 children who had received one dose under one year of age and a second dose at the age of one.
Group D, comprising 163 unvaccinated children with a history of measles in the past.
The parents were always asked to consent to the drawing of a blood sample from their children.
Laboratory tests. Blood samples wereobtained by venopuncture. After centrifugation the sera were stored at -20°C. Specific antibodies for measles virus were detected through hemagglutinationinhibition test (HI), and, when titers were below 8, a virus neutralization test (NT) was performed19 26. The titer was considered as the reciprocai of the end-point dilution.
The children who had HI titers below 8 and NT negative were considered as susceptible to measles.
Statistical analysis. Frequency distributions were analysed by the chi-square test and the differencesconsidered significant at theO.Ol levei. The geometric mean HI antibody titers were calculated and a t-test (Student) was carried out to compare these titers22.
RESULTS
Group A. It was found that the frequency of HI titers below 8 diminished throughout the years in the group (Table 1 ). In the age group under 2 years of age, 48.2% no measles antibody was detected. However, in the 10-15 years age group this percentage fell to 4.5%. It was observed that the highest titers were found in children vaccinated long ago (Table 2) .
Better results were found when the NT test was used in the negative HI cases but even so 25.9 % and 18.3 % of the children of Group A had no detectable antibody in the age groups under 2 years and 2-4 years of age, respectively ( Figure 2 ). Less frequently this fact was also detected in the following age groups. Of ali the cases studied in Group A only 8.2% had been vaccinated before 9 months of age.
Group B. The results of this group are shown in Table 1 . It can be seen that the percentages of cases with HI titers below 8 diminished throughout the years. However, thedifferenceamongthemwas notsogreat, i. e.: under2years: 13.0%; 2 -4 years: 11.8% and 5-9 years of age: 8.2%. Also, important variations were not observed among the geometric mean of the HI antibody titers as calculated for each age group (Table 2) .
As in Group A, it was verified that the frequency of children with detectable antibodies in Group B increased when the NT was employed to evaluate the HI negative samples (Table 1) . Measles antibodies were found in ali children under 2 years of age and, in the age groups of 2-4 years and 5-9 years of age, in 94.1% and 96.7%, respectively (Figure 2) . Group C. In this group the percentage of cases with HI titers below 8 increased with age, being 8.0 % in children under 2 years of age and 17.2 % in those between 2-4 years of age (Table 1) . However, the geometric mean of HI antibody titer was nearly the same in the two age groups studied ( Table 2) .
A similar result was observed when the NT was employed in the HI negative samples. Measles antibodies were detected in 96.0 % of the age groups above mentioned.
Group D. As indicated in Table 1 , in 159 cases out of 163 of children with a past history of measles (97.5%), specific antibodies were detected either by HI or NT. The geometric mean HI antibody titers declined throughout the years after the disease and this was more pronounced until 4 years of age.
Comparative study. In the age group under 2 years, the value of the geometric mean HI antibody titers found in Group A (9.25) were nearly three times lower than those observed in Groups B (25.10) and C (26.35). In the following age groups, this difference diminished mainly due to the elevation of the Group A mean titers.
The percentage of measles antibodies measured by HI or NT ( Figure 2) were also lower than those found in Groups B and C. In the age group under 2 years, ali the children of Group B and 96 % of Group C had measles antibodies against only 74.1 % of Group A. In the following time intervals studied those differences decreased although a statistically significant difference between Group A and B, in the age group 2-4 years (x2: 10.78 -P < 0.01) still existed.
The geometric mean HI antibody titers of Group D (Figure 1) were always higher than the other groups, mainly when compared to the value found in Group A. This difference was more pronounced in the age groups 2-4 years and 5-9 years of age. In relation to the frequency of antibodies measured by HI and NT (Figure 2 ) it was also verified that the percentages were higher in the children of Group D than those of Group A. This fact was not observed when Group D was compared to the other groups of vaccinees (B and C). Note: ( -) A ge groups not studied due to few cases obtained.
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DISCUSSION
Studies made to evaluate measles immunity in children vaccinated at less than one year of age have shown that about 45% of them had HI antibody titers below 1032. Apart from this, more than 40% of vaccine failures are related in subjects that received this product in that age group5 615 33. These children presented lower seroconversion rates and antibody titers when compared to those that vaccinees with one year of age or older1 10 18 28. In Halsey's8 opinion it is possible that the former group is more capable to lose their antibodies throughout future years.
In the present research it was shown that the percentage of measles antibodies measured by HI and NT in children vaccinated under one year (Group A) was always lower than those vaccinated at one year of age (Group B). In the age group under 2 years, ali Group B children had measles antibodies in contrast to 74.1 % of Group A. Although this difference had diminished throughout the years, it was significant (P < 0.01) up to the age of four.
Also the geometric mean HI antibody titers of Group A were always lower than those found for Group B in the age groups studied, mainly in children under 2 years old. While the pattem of the mean titer of HI antibodies in Group C (vaccinated with two doses) was similar to that verified for Group B.
The results of this research suggest that the age at vaccination can be considered as a significant factor in the frequency of measles antibody in the group studied. Probably this fact can be due to the presence of maternal antibodies in infants vaccinated before the age o f one. It was also found that the frequency of antibody and the geometric mean HI antibody titer of Group A progressively increased throughout the years while the values of Group B and C remained stable, with little variations. Subclinical reinfection with measles virus in Group A children could explain this finding since overt clinicai disease had been denied by parents in ali the cases studied.
In large clusters of vaccinees antibody titers may change according to the intensity of wild virus circulation. In closed populations these titers progressively decrease12 but in open populations the antibody leveis remain high, presumably as a Oliveira 26:77-82, abr-jun, 1993. result of re-exposure to wild virus13 14 27.
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Ruiz-Gomez and associates27 established a correlation between the time elapsed between vaccination and blood collection. Their results are similar to those presented in the present paper, i. e ., increase in the frequency of measles antibodies throughout the years. However, they did not find a parallel increase of geometric mean titers. The authors believe that this finding could be due to subclinical reinfections with the wild virus.
Antibody leveis after vaccination are lower than those found in subjects who had natural measles3 9 25. This difference is due to attenuation of wild virus during vaccine production30.
In our study vaccinated children (Groups A, B and C) were also compared to those with a history of measles in the past (Group D). The geometric mean HI antibody titers of Group D were always higher than the values found for the vaccinees. However, this difference was more pronounced when Group D was compared to Group A, mainly during the first five years after vaccination. These findings were not affected by the age at vaccination and doses of vaccine received.
Moreover, alterations in measles vaccinequality in use in health units could also have contributed to the results above related. Oliveira and associates, in 198620 and, again in 1990 (Oliveira SA and associates: data not published), carried out an investigation to evaluate the basic procedures involved in the storage of measles vaccine in public health units of the same Municipalities studied here. The first research showed inadequacy and lack of uniformity, at regional and local leveis, conceming conditions of vaccine storage as well as insufficient training of health workers. Ali vaccine samples titers were well under the minimal recommended potency by the manufacturers. Four years later, despite the improvement of the cold chain when compared to the former evaluation, 55.2% of the vaccine samples were still under the minimal recommended potency.
The age at vaccination was the factor that mostly influenced the results of this project. So, based on our data and those from literature5 61516 21 32 33 we suggest for developing countries a twodose vaccination schedule against measles that includes an early first dose at nine months of age and revaccination after 12 months of age. 
RESUMO
